查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1442606

全球远距患者监护 (RPM) 市场评估：按产品、应用程式、最终用户、地区、机会和预测（2017-2031 年）

Remote Patient Monitoring Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 235 Pages | 商品交期: 3-5个工作天内

价格

全球远距病患监护 (RPM) 市场规模预计将从 2023 年的 95.3 亿美元增长到 2031 年的 258 亿美元，预测期内复合年增长率为 13.26%。Masu。

市场扩张的推动因素是人们越来越意识到与远距患者监护 (RPM) 和远距医疗相关的各种成本效益，以及市场上各主要参与者对 RPM 的投资增加。 RPM 系统和设备通常用于帮助需要出院后护理或患有慢性病的患者。 透过使用 RPM 解决方案监控高风险患者的健康状况和生命体征，组织可以在患者就诊之间更新数据并通知患者潜在的健康问题。 RPM 设备可增强患者参与度、改善护理并使患者更容易获得医疗保健。 人们越来越认识到使用 RPM 设备和服务带来的各种好处，促使多家医院实施这些系统，这是主要的成长动力。

增加投资与策略联盟支持市场成长

各医院和医疗中心增加对 RPM 系统和软体的投资，以提高患者便利性和改善患者护理，也推动了市场成长。 2024 年 1 月，班加罗尔的阿波罗医院 Seshadripuram 宣布与一家名为 LifeSigns 的人工智慧健康监测技术公司建立合作伙伴关係。 此次合作预计将透过为医院提供无线 RPM 系统，显着推进主动病患管理和精准医疗。

慢性病和老年人口的增加正在推动市场扩张

人们越来越认识到在慢性病管理中实施 RPM 的各种好处，为市场提供了有利的成长机会。 许多医疗保健提供者利用 RPM 来照顾患有癌症、糖尿病、心血管疾病和慢性肺病等慢性疾病的患者。 RPM 让医疗保健提供者收集相关数据、追踪患者健康状况并采取必要的干预措施以避免不良事件。 远端患者管理可以透过追踪患者生命体征并提醒患者、其照护者和医疗保健提供者必要的信息，成为慢性病管理的重要工具。 例如，对于糖尿病，RPM 会追踪患者的血糖水平、体力活动和胰岛素摄取量。 根据世界卫生组织(WHO)预测，到2050年左右，每年9,000万人的死亡中，糖尿病、心血管疾病、呼吸系统疾病和癌症等慢性病将占86%。 由于此类慢性疾病的盛行率不断增加，对 RPM 市场的需求不断增加。

本报告调查了全球远距病患监护(RPM) 市场，并提供了市场定义和概述、市场规模趋势和预测、各个细分市场和地区的详细分析、行业结构和市场成长趋势。其中包括影响因素分析、案例研究、竞争格局和主要公司简介。

目录

第 1 方法

第 2 章专案范围与定义

第 3 章执行摘要

第 4 章全球远距病患监护 (RPM) 市场展望

  • 市场规模/预测
  • 按产品
    • 特殊监视器
    • 生命征象监测仪
    • 软体
    • 服务
  • 依用途
    • 心血管疾病
    • 体重管理/健康监测
    • 睡眠障碍
    • 传染病
    • 癌症
    • 脱水
    • 高血压
    • 其他
  • 按最终用户
    • 门诊
    • 家庭医疗护理
    • 住院病人
    • 其他
  • 按地区
    • 北美
    • 南美洲
    • 欧洲
    • 亚太地区
    • 中东/非洲
  • 各公司的市占率

第 5 章按地区划分的全球远距病患监护 (RPM) 市场展望

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东/非洲

第 6 章市场映射

  • 按产品
  • 依用途
  • 按最终用户
  • 按地区

第 7 环境与产业结构

  • 需求与供给分析
  • 汇入/汇出分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市场动态

  • 生长促进因素
  • 生长抑制因素（问题/抑制因素）

第 9 章法律与监管架构/创新

  • 专利环境
  • 监理机关核准
  • 创新/新兴技术

第 10 章主要公司状况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 位市场领导者的市场收入分析
  • 併购/合资企业（如果适用）
  • SWOT 分析（5 家参与公司）
  • 专利分析（如果适用）

第 11 章价格分析

第 12 章案例研究

第 13 章主要公司展望

  • Abbott Laboratories
  • OMRON Corporation
  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Boston Scientific Corporation
  • Nihon Kohden Corporation
  • Johnson & Johnson
  • BIOTRINIK SE & Co.
  • MD Revolution

第 14 章策略建议

第 15 章关于我们公司/免责声明

Product Code: MX11074

Global remote patient monitoring market is projected to witness a CAGR of 13.26% during the forecast period 2024-2031, growing from USD 9.53 billion in 2023 to USD 25.8 billion in 2031. The market expansion is supported by the growing awareness about the various cost benefits associated with remote patient monitoring (RPM) and telehealth and rising investments towards RPM by various key players in the market. Remote patient monitoring systems and devices are often used to help patients who require post-discharge care or are suffering from chronic diseases. Using RPM solutions to monitor the health and vitals of high-risk patients allows organizations to stay updated with data between patient visits and notify them about any potential health issues. RPM devices enhance patient engagement, improve care, and allow patients to have better access to healthcare. Due to the growing awareness about the various advantages associated with the utilization of remote patient monitoring devices and services, several hospitals are adopting such systems, thereby acting as a major growth-inducing factor.

For instance, in 2023, AJ Hospital and Research Centre in Mangaluru adopted an AI-based continuous and contactless remote patient monitoring (RPM) and early warning system (EWS) created by Dozee on fifty beds in their private ward. The early warning system allows the tracking of vital parameters and ensures the provision of alerts to healthcare providers for timely medical intervention in case of patient's clinical deterioration.

Increasing Investments and Strategic Collaborations Support Market Growth

Rising investments by various hospitals and healthcare centers towards remote patient monitoring systems and software to enhance patient convenience and improve patient care is bolstering the remote patient monitoring market growth. In January 2024, a renowned multispecialty hospital in Bangalore, Apollo Hospital Seshadripuram, announced a partnership with an AI-powered health monitoring technology company called LifeSigns. The collaboration is expected to mark a significant advancement in proactive patient management and precision healthcare by empowering the hospital with a wireless remote patient monitoring system. The hospital's commitment to digital transformation will ensure the continuous integration of upgraded LifeSigns solutions in their core operations. They are also going to ensure that the systems are available to all their patients from now onwards. The system uses biosensors for continuously tracking vital signs, including SPO2, blood pressure, and ECG, among others. The secure transmission of real-time data to a platform accessible to healthcare professionals will facilitate continuous monitoring, allowing early identification of any potential complications.

Rising Prevalence of Chronic Diseases and Geriatric Population Boosts Market Expansion

The growing awareness about the various advantages associated with the adoption of remote patient monitoring for the management of chronic diseases is providing lucrative growth opportunities to the market. Various healthcare providers are leveraging remote patient monitoring to provide care for patients suffering from chronic diseases, including cancer, diabetes, cardiovascular diseases, and chronic lung diseases. RPM allows healthcare providers to collect relevant data, track patient health, and make necessary interventions to avoid adverse events. Remote patient management acts as a valuable tool for chronic disease management by tracking the vitals of the patients and alerting them and their caregivers and healthcare providers about necessary information. For instance, in diabetes, RPM tracks the blood sugar levels of the patient, along with physical activity and insulin intake. Remote patient monitoring aims to provide better care to patients by understanding their condition and closely tracking their progress. According to the World Health Organization (WHO), by around 2050, various chronic diseases, including diabetes, cardiovascular diseases, respiratory diseases, and cancer, will account for 86% of the 90 million deaths every year. The remote patient monitoring market demand is increasing due to the growing prevalence of such chronic diseases.

North America Accounts for a Significant Share of the Market

The expansion of the market in the region can be attributed to growing emphasis on the adoption of the Internet of Things (IoT) medical devices, rising investments in telehealth, and the strong presence of various market players. As per a Harvard Health Letter article published in December 2022, approximately 50 million individuals in the United States alone use remote patient monitoring devices. One of the first RPM devices to be adopted was home blood pressure machines. The increasing prevalence of heart diseases and strokes in the region is further bolstering the demand for remote patient monitoring devices. According to Centre for Disease Control and Prevention, over 877,500 Americans die from stroke and heart diseases, among other cardiovascular diseases every year. Heart disease is the leading cause of death in the United States, while stroke takes the fifth position among all deaths in the United States. Remote patient monitoring allows the utilization of electronic devices to record relevant data of a patient for review and evaluation later by their healthcare provider or physician.

For instance, a patient can use RPM devices for regular monitoring of their blood pressure and share the results with their regular physician. The increasing awareness about the various advantages associated with the utilization of RPM devices is supporting the growth of the North America remote patient monitoring market.

Special Monitors Anticipated to Witness Significant Growth in the Coming Years

The increase in utilization and demand of special monitors, such as blood glucose monitors, anesthesia monitors, and multi-parameter monitors, over the forecast period can be attributed to the growing requirement for monitoring clinically important and pre- and post-surgery data for identification of systems and prevention of complications.

For instance, regularly monitoring blood glucose levels is essential for patients with diabetes as they, at times, do not feel any symptoms that are associated with diabetes until the blood glucose levels become too high. The utilization of RPM devices for monitoring blood glucose levels allows practitioners to use the captured data for detecting potential alarming changes in the levels of glucose and take necessary actions immediately. Additionally, the collected data can also provide insights to practitioners that will aid them in recommending necessary alterations in exercise, medications, and diet. Remote patient monitoring also allows the effective mitigation of gestational diabetes. As per the Centre for Disease Control and Prevention, approximately 1-2% of pregnant women in the United States have either Type 1 or Type 2 diabetes and nearly 6-9% of women develop gestational diabetes during pregnancy.

Rising Utilization of RPM for Cardiovascular Diseases

The potential of remote patient monitoring in reducing the burden of managing and monitoring cardiovascular diseases is resulting in a burgeoning volume of research. The research activities aim to evaluate the economic and clinical effectiveness of RPM. According to an article published by American Heart Association, it is projected that by 2035, over 42% of adults in the United States will be hypertensive. The cost projections for hypertension are daunting, with 2035 figures to soar over USD 150 billion. Remote patient monitoring is expected to serve as a vital conduit for reducing the economic burden stemming from expensive hospital stays because of acute hypertension related events. Research has shown that remote patient monitoring can reduce diastolic blood pressure and systolic blood pressure significantly as compared to self-monitoring. Additional studies have shown that the positive impact of remote patient monitoring on systolic blood pressure can increase if the intervention includes multiple behavior change techniques and is long-term.

Future Market Scenario (2024 - 2031F)

The broader use of remote patient monitoring, guided with operational knowledge and high-quality research, is expected to support advancements in hospitals and at home models of care. It has significant potential to benefit from the value provided by healing in the comfort of home.

In February 2024, MD Revolution announced that their partner, Cardiac Solutions, achieved a 50% reduction in the rate of hospital cardiovascular readmission by using chronic care management and RevUp Remote Patient Monitoring as part of their program. The conducted study showed sustained benefits on an annual basis and demonstrated high cost-saving potential and efficacy.

Key Players Landscape and Outlook

Key participants in the remote patient monitoring market include OMRON Corporation, Koninklijke Philips N.V., F. Hoffmann-La Roche AG, GE Healthcare, and Abbott Laboratories. In 2023, OMRON Healthcare India announced collaboration with Tricog, a Bengaluru-based firm. This collaboration is expected to be OMRON's foray into remote heart management and monitoring segment.

In May 2023, Abbott received U.S. Food and Drug Administration (FDA) clearance for their Assert-IQ insertable cardiac monitor (ICM). This clearance expands the company's portfolio of connected health devices that can aid doctors in treating their patients remotely.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Remote Patient Monitoring Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Product
    • 4.2.1. Special Monitor
      • 4.2.1.1. Blood Glucose Monitors
      • 4.2.1.2. Anesthesia Monitors
      • 4.2.1.3. Multi-Parameter Monitors
      • 4.2.1.4. Others
    • 4.2.2. Vital Sign Monitor
      • 4.2.2.1. Temperature Monitors
      • 4.2.2.2. Blood Pressure Monitors
      • 4.2.2.3. Respiratory Rate Monitors
      • 4.2.2.4. Others
    • 4.2.3. Software
    • 4.2.4. Services
  • 4.3. By Application
    • 4.3.1. Cardiovascular Diseases
    • 4.3.2. Weight Management and Fitness Monitoring
    • 4.3.3. Sleep Disorder
    • 4.3.4. Infections
    • 4.3.5. Cancer
    • 4.3.6. Dehydration
    • 4.3.7. Hypertension
    • 4.3.8. Others
  • 4.4. By End-user
    • 4.4.1. Ambulatory Patients
    • 4.4.2. Home Healthcare
    • 4.4.3. Hospital-Based Patients
    • 4.4.4. Others
  • 4.5. By Region
    • 4.5.1. North America
    • 4.5.2. South America
    • 4.5.3. Europe
    • 4.5.4. Asia-Pacific
    • 4.5.5. Middle East & Africa
  • 4.6. By Company Market Share (%), 2023

5. Global Remote Patient Monitoring Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Product
      • 5.1.2.1. Special Monitors
      • 5.1.2.1.1. Blood Glucose Monitors
      • 5.1.2.1.2. Anesthesia Monitors
      • 5.1.2.1.3. Multi-Parameter Monitors
      • 5.1.2.1.4. Others
      • 5.1.2.2. Vital Sign Monitors
      • 5.1.2.2.1. Temperature Monitors
      • 5.1.2.2.2. Blood Pressure Monitors
      • 5.1.2.2.3. Respiratory Rate Monitors
      • 5.1.2.2.4. Others
      • 5.1.2.3. Software
      • 5.1.2.4. Services
    • 5.1.3. By Application
      • 5.1.3.1. Cardiovascular Diseases
      • 5.1.3.2. Weight Management and Fitness Monitoring
      • 5.1.3.3. Sleep Disorder
      • 5.1.3.4. Infections
      • 5.1.3.5. Cancer
      • 5.1.3.6. Dehydration
      • 5.1.3.7. Hypertension
      • 5.1.3.8. Others
    • 5.1.4. By End-user
      • 5.1.4.1. Ambulatory Patients
      • 5.1.4.2. Home Healthcare
      • 5.1.4.3. Hospital-Based Patients
      • 5.1.4.4. Others
    • 5.1.5. United States*
      • 5.1.5.1. Market Size & Forecast
      • 5.1.5.1.1. By Value
      • 5.1.5.1.2. By Volume
      • 5.1.5.2. By Product
      • 5.1.5.2.1. Special Monitors
      • 5.1.5.2.1.1. Blood Glucose Monitors
      • 5.1.5.2.1.2. Anesthesia Monitors
      • 5.1.5.2.1.3. Multi-Parameter Monitors
      • 5.1.5.2.1.4. Others
      • 5.1.5.2.2. Vital Sign Monitors
      • 5.1.5.2.2.1. Temperature Monitors
      • 5.1.5.2.2.2. Blood Pressure Monitors
      • 5.1.5.2.2.3. Respiratory Rate Monitor
      • 5.1.5.2.2.4. Others
      • 5.1.5.2.3. Software
      • 5.1.5.2.4. Services
      • 5.1.5.3. By Application
      • 5.1.5.3.1. Cardiovascular Diseases
      • 5.1.5.3.2. Weight Management and Fitness Monitoring
      • 5.1.5.3.3. Sleep Disorder
      • 5.1.5.3.4. Infections
      • 5.1.5.3.5. Cancer
      • 5.1.5.3.6. Dehydration
      • 5.1.5.3.7. Hypertension
      • 5.1.5.3.8. Others
      • 5.1.5.4. By End-user
      • 5.1.5.4.1. Ambulatory Patients
      • 5.1.5.4.2. Home Healthcare
      • 5.1.5.4.3. Hospital-Based Patients
      • 5.1.5.4.4. Others
    • 5.1.6. Canada
    • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product
  • 6.2. By Application
  • 6.3. By End-user
  • 6.4. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Patent Landscape
  • 9.2. Regulatory Approvals
  • 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Abbott Laboratories
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. OMRON Corporation
  • 13.3. Koninklijke Philips N.V.
  • 13.4. F. Hoffmann-La Roche AG
  • 13.5. GE Healthcare
  • 13.6. Boston Scientific Corporation
  • 13.7. Nihon Kohden Corporation
  • 13.8. Johnson & Johnson
  • 13.9. BIOTRINIK SE & Co.
  • 13.10. MD Revolution

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 2. Global Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 3. Global Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 4. Global Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 5. Global Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 6. Global Remote Patient Monitoring Market Share (%), By Region, 2017-2031F
  • Figure 7. North America Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 8. North America Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 9. North America Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 10. North America Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 11. North America Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 12. North America Remote Patient Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 13. United States Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 14. United States Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 15. United States Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 16. United States Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 17. United States Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 18. Canada Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 19. Canada Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 20. Canada Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 21. Canada Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 22. Canada Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 23. Mexico Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 24. Mexico Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 25. Mexico Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 26. Mexico Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 27. Mexico Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 28. Europe Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 29. Europe Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 30. Europe Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 31. Europe Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 32. Europe Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Remote Patient Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 34. Germany Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 35. Germany Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 36. Germany Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 37. Germany Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 38. Germany Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 39. France Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 40. France Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 41. France Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 42. France Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 43. France Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 44. Italy Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 45. Italy Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 46. Italy Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 47. Italy Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 48. Italy Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 49. United Kingdom Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 50. United Kingdom Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 51. United Kingdom Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 52. United Kingdom Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 53. United Kingdom Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 54. Russia Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 55. Russia Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 56. Russia Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 57. Russia Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 58. Russia Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 59. Netherlands Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 60. Netherlands Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 61. Netherlands Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 62. Netherlands Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 63. Netherlands Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 64. Spain Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 65. Spain Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 66. Spain Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 67. Spain Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 68. Spain Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 69. Turkey Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 70. Turkey Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 71. Turkey Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 72. Turkey Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 73. Turkey Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 74. Poland Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 75. Poland Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 76. Poland Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 77. Poland Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 78. Poland Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 79. South America Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 80. South America Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 81. South America Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 82. South America Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 83. South America Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 84. South America Remote Patient Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 85. Brazil Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 86. Brazil Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 87. Brazil Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 88. Brazil Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 89. Brazil Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 90. Argentina Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 91. Argentina Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 92. Argentina Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 93. Argentina Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 94. Argentina Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 95. Asia-Pacific Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 96. Asia-Pacific Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 97. Asia-Pacific Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 98. Asia-Pacific Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 99. Asia-Pacific Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 100. Asia-Pacific Remote Patient Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 101. India Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 102. India Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 103. India Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 104. India Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 105. India Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 106. China Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 107. China Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 108. China Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 109. China Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 110. China Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 111. Japan Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 112. Japan Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 113. Japan Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 114. Japan Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 115. Japan Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 116. Australia Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 117. Australia Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 118. Australia Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 119. Australia Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 120. Australia Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 121. Vietnam Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 122. Vietnam Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 123. Vietnam Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 124. Vietnam Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 125. Vietnam Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 126. South Korea Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 127. South Korea Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 128. South Korea Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 129. South Korea Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 130. South Korea Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 131. Indonesia Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 132. Indonesia Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 133. Indonesia Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 134. Indonesia Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 135. Indonesia Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 136. Philippines Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 137. Philippines Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 138. Philippines Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 139. Philippines Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 140. Philippines Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 141. Middle East & Africa Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 142. Middle East & Africa Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 143. Middle East & Africa Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 144. Middle East & Africa Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 145. Middle East & Africa Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 146. Middle East & Africa Remote Patient Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 147. Saudi Arabia Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 148. Saudi Arabia Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 149. Saudi Arabia Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 150. Saudi Arabia Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 151. Saudi Arabia Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 152. UAE Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 153. UAE Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 154. UAE Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 155. UAE Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 156. UAE Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 157. South Africa Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
  • Figure 158. South Africa Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
  • Figure 159. South Africa Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 160. South Africa Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 161. South Africa Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 162. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023